Additional file 7 of Lycorine transfersomes modified with cell-penetrating peptides for topical treatment of cutaneous squamous cell carcinoma

Additional file 7: Figure S7. Histopathology of tissue sections of the skin with cutaneous squamous cell carcinoma (cSCC) tumor stained using hematoxylin and eosin after 14 days of treatment. Scale bar: 400 μm

Additional file 1 of Lycorine transfersomes modified with cell-penetrating peptides for topical treatment of cutaneous squamous cell carcinoma

Additional file 1: Figure S1. 1H-NMR (600 MHz) spectrum of R5H3 (A) and Stearyl-H3R5 (B)

Additional file 6 of Lycorine transfersomes modified with cell-penetrating peptides for topical treatment of cutaneous squamous cell carcinoma

Additional file 6: Figure S6. Average tumor weight of mice in each group after 14 days of treatment. *p < 0.05, **p < 0.01, and ***p < 0.001

Additional file 5 of Lycorine transfersomes modified with cell-penetrating peptides for topical treatment of cutaneous squamous cell carcinoma

Additional file 5: Figure S5. Representative images of cutaneous squamous cell carcinoma (cSCC) tumor-bearing nude mice treated with various formulations

Additional file 2 of Lycorine transfersomes modified with cell-penetrating peptides for topical treatment of cutaneous squamous cell carcinoma

Additional file 2: Figure S2. Representative image of cell-penetrating peptide modified lycorine transfersomes with components of 1,2-dioleoyl-3-trimethylammonium-propane and sodium cholate hydrate (LR@DTFs-CPP)